SMITH ASSET MANAGEMENT GROUP LP - SUNESIS PHARMACEUTICALS INC ownership

SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 103 filers reported holding SUNESIS PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.

Quarter-by-quarter ownership
SMITH ASSET MANAGEMENT GROUP LP ownership history of SUNESIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2014$1,450,000
+9.1%
203,128
-0.3%
0.05%
+10.2%
Q2 2014$1,329,000
-5.8%
203,838
-4.5%
0.05%
-9.3%
Q1 2014$1,411,000
+38.7%
213,433
-0.5%
0.05%
+38.5%
Q4 2013$1,017,000
-5.0%
214,597
-0.5%
0.04%
-11.4%
Q3 2013$1,070,000
-13.3%
215,759
-9.4%
0.04%
-17.0%
Q2 2013$1,234,000238,0380.05%
Other shareholders
SUNESIS PHARMACEUTICALS INC shareholders Q2 2014
NameSharesValueWeighting ↓
RA Capital Management 4,869,261$32,186,0002.31%
GREAT POINT PARTNERS LLC 193,567$1,279,0000.67%
Visium Asset Management, LP 4,526,750$29,922,0000.48%
Healthcare Value Capital, LLC 103,185$682,0000.45%
ALYDAR PARTNERS LLC 550,565$3,639,0000.36%
Rhenman & Partners Asset Management AB 147,403$974,0000.29%
HealthCor Management, L.P. 690,000$4,561,0000.27%
Sivik Global Healthcare LLC 63,087$417,0000.26%
PALISADE CAPITAL MANAGEMENT, LP 1,379,278$9,117,0000.22%
Healthcare Value Capital, LLC 50,000$331,0000.22%
View complete list of SUNESIS PHARMACEUTICALS INC shareholders